Back to BAYRYView Full LandscapeView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
6 competitors in Carcinoma, Non-Small-Cell Lung
PBYIHKI-272
Phase 2JNJJNJ-90301900
Phase 2LLYIMC-1121B (ramucirumab)
Phase 2CASIrecombinant human Angiostatin protein
Phase 2GTHXG1T38
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Developer
Related Pipeline
FondaparinuxPhase 3
Superficial Vein Thrombosis
aflibercept 8 mgPhase 3
Polypoidal Choroidal Vasculopathy
Levofloxacin & MetronidazolePhase 3
Pelvic Inflammatory Disease
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & RifampicinPhase 3
Pulmonary Tuberculosis
meropenem, moxifloxacinPhase 3
Severe Sepsis
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts